Biocon Ltd
NSE:BIOCON
Biocon Ltd
Cash from Operating Activities
Biocon Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biocon Ltd
NSE:BIOCON
|
Cash from Operating Activities
₹11.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
53%
|
CAGR 10-Years
14%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Cash from Operating Activities
₹108.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Cash from Operating Activities
₹2.3k
|
CAGR 3-Years
-88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Cash from Operating Activities
₹141.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Cash from Operating Activities
₹236m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Cash from Operating Activities
-₹4.2B
|
CAGR 3-Years
-141%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Cash from Operating Activities?
Cash from Operating Activities
11.7B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Cash from Operating Activities amounts to 11.7B INR.
What is Biocon Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%
Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for Biocon Ltd have been 5% over the past three years , 53% over the past five years , and 14% over the past ten years .